Cargando…

Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system

OBJECTIVE: To assess the efficacy of the FIGO 2018 classification system for nodal-specific classifications for early-stage cervical cancer; specifically, to examine the impact of nodal metastasis on survival and the effect of postoperative treatments, according to histological subtypes. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Machida, Hiroko, Matsuo, Koji, Kobayashi, Yoichi, Momomura, Mai, Takahashi, Fumiaki, Tabata, Tsutomu, Kondo, Eiji, Yamagami, Wataru, Ebina, Yasuhiko, Kaneuchi, Masanori, Nagase, Satoru, Mikami, Mikio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024192/ https://www.ncbi.nlm.nih.gov/pubmed/35320882 http://dx.doi.org/10.3802/jgo.2022.33.e26

Ejemplares similares

Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study
por: Kondo, Eiji, et al.
Publicado: (2021)

Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer
por: Matsuo, Koji, et al.
Publicado: (2019)

Proposal of a Two-Tier System in Grouping Adenocarcinoma of the Uterine Cervix
por: Machida, Hiroko, et al.
Publicado: (2020)

Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JSGO-JSOG joint study
por: Seino, Manabu, et al.
Publicado: (2022)

Impact of lymphadenectomy on the treatment of endometrial cancer using data from the JSOG cancer registry
por: Saotome, Keiko, et al.
Publicado: (2021)

Reviewing FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2023)

Surgically treated cervical cancer in a high-risk group in the era of the 2018 FIGO staging schema: a nationwide study
por: Shigeta, Shogo, et al.
Publicado: (2023)

Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study
por: Matsuo, Koji, et al.
Publicado: (2019)

Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan
por: Machida, Hiroko, et al.
Publicado: (2019)

Implications of the revised cervical cancer FIGO staging system
por: Bhatla, Neerja, et al.
Publicado: (2021)

Critical analysis of the FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2022)

Trachelectomy for stage IB1 cervical cancer with tumor size >2 cm: trends and characteristics in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee
por: Ikeda, Masae, et al.
Publicado: (2021)

Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
por: Yamagami, Wataru, et al.
Publicado: (2019)

Quality indicators for cervical cancer care in Japan
por: Watanabe, Tomone, et al.
Publicado: (2018)

Ovarian conservation for young women with clinical stage IB–IIB cervical cancer in Japan
por: Matsuo, Koji, et al.
Publicado: (2017)

Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer
por: Long, Xingtao, et al.
Publicado: (2023)

Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients
por: Mabuchi, Seiji, et al.
Publicado: (2017)

Neoadjuvant Chemotherapy with Taxane and Platinum Followed by Radical Hysterectomy for Stage IB2-IIB Cervical Cancer: Impact of Histology Type on Survival
por: Matsuo, Koji, et al.
Publicado: (2019)

A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri
por: Berek, Jonathan S., et al.
Publicado: (2018)

Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer
por: Yamazaki, Hiroyuki, et al.
Publicado: (2015)

Identifying selection criteria for non‐radical hysterectomy in FIGO stage IB cervical cancer
por: Kasamatsu, Takahiro, et al.
Publicado: (2019)

Discussion on the Treatment Strategy for Stage ⅡA1 Cervical Cancer (FIGO 2018)
por: Chen, Xiaolin, et al.
Publicado: (2022)

Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer
por: Chang, Hong, et al.
Publicado: (2023)

Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
por: Ye, Yanna, et al.
Publicado: (2023)

Validation of the 2018 FIGO Staging System of Cervical Cancer for Stage III Patients with a Cohort from China
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Should the Number of Metastatic Pelvic Lymph Nodes Be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer?
por: Pedone Anchora, Luigi, et al.
Publicado: (2020)

FIGO 2018 Staging for Cervical Cancer: Influence on Stage Distribution and Outcomes in the 3D-Image-Guided Brachytherapy Era
por: Tomizawa, Kento, et al.
Publicado: (2020)

Influence of New FIGO 2018 Staging on Treatment Outcomes in Early-Stage Cervical Cancer: A Single-Center Study
por: Kaur, Satinder, et al.
Publicado: (2022)

Indications for endoscopy according to the revised FIGO staging for cervical cancer after MRI and CT scanning
por: Jeong, Bae Kwon, et al.
Publicado: (2012)

Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
por: Chai, Yanlan, et al.
Publicado: (2014)

Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors
por: Yan, Ding-Ding, et al.
Publicado: (2019)

Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review
por: Qin, Fengying, et al.
Publicado: (2022)

A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma
por: Yamagami, Wataru, et al.
Publicado: (2020)

Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review
por: Murakami, Isao, et al.
Publicado: (2023)

Escalated radiation and prophylactic extended field nodal irradiation are beneficial for FIGO IIIB cervical cancer patients’ prognosis
por: Meng, Qingyu, et al.
Publicado: (2018)

Quality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB–IIB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2018)

Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer
por: Nishio, Shin, et al.
Publicado: (2018)

Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2–IVA cervical cancer and its clinical prognostic factors
por: Fujiwara, Masateru, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j81nv2ful4m46altcrvech6d9m